Molina Healthcare Reports Third Quarter 2025 Financial Results

Molina Healthcare's premium revenue for the quarter ending September 30, 2025, reached $10.841 billion, up from $9.694 billion in the same quarter of the previous year. This surge signifies a robust increase in premium revenue, attributed primarily to the company’s expanding membership and improved healthcare delivery capabilities.

The total revenue also saw a substantial increase, amounting to $11.477 billion, compared to $10.340 billion for the same period in 2024. Cumulatively, for the nine months ending September 30, 2025, total revenue stood at $34.051 billion, compared to $30.151 billion in the previous year.

The net income for the third quarter of 2025 was reported at $79 million, yielding a GAAP diluted EPS of $1.51. In contrast, the net income for the same quarter in 2024 was $326 million, with a diluted EPS of $5.65. This decline in net income and EPS indicates challenges faced in managing costs and maintaining profitability amidst rising medical expenses.

On an adjusted basis, the net income was $97 million, leading to an adjusted diluted EPS of $1.84. This is a decrease from the adjusted net income of $347 million and an EPS of $6.01 reported in the third quarter of 2024.

Molina’s Medical Care Ratio (MCR) for the third quarter was 92.6%, a notable increase from 89.2% in the prior year. This rise indicates that a higher percentage of premiums is being utilized for medical services, which could suggest an increase in medical claims or elevated healthcare costs.

The General and Administrative (G&A) ratio remained relatively stable, reported at 6.4% for the third quarter of 2025, compared to 6.5% in the same quarter of the previous year. This consistency in administrative efficiency suggests that the company is managing its operational costs effectively, even as it navigates the complexities of the healthcare market.

The after-tax margin for Molina Healthcare was reported at 0.7% for the third quarter, a significant drop from 3.2% in the prior year. This decline reflects the pressures faced by the company, emphasizing the need for strategic adjustments to improve profitability.

On an adjusted basis, the after-tax margin stood at 0.8%, down from 3.4% in the same quarter of 2024, indicating that while the company is still generating positive earnings, the margin of profitability is tightening.

Molina Healthcare’s third-quarter results for 2025 present a complex picture of growth amid challenges. While the company has made strides in increasing its premium and total revenue, the rising medical care ratio and declining profit margins highlight areas that require focused attention. Moving forward, Molina will need to balance its growth strategy with effective cost management to enhance profitability and continue delivering value to its members and shareholders.